medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Number 1

<< Back Next >>

Ann Hepatol 2012; 11 (1)

Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease

Chavez-Tapia NC, Kinney-Novelo IM, Sifuentes-Rentería SE, Torres-Zavala M, Castro-Gastelum G, Sánchez-Lara K, Paulin-Saucedo C, Uribe M, Méndez-Sánchez N

Language: English
References: 15
Page: 85-89
PDF size: 73.79 Kb.


ABSTRACT

Objective. Gallbladder disease and cardiovascular disease share risk factors. Both have a great impact on the economics of health systems. There is evidence suggesting an increased risk of cardiovascular disease in patients with gallbladder disease, but the association of gallbladder disease with other risk factors for cardiovascular disease is unclear. The aim of this study is to analyse the relationship between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Material and methods. This is a case-control study comparing subjects undergoing cholecystectomy with controls without gallbladder disease or cholecystectomy. Demographic, anthropometric, and biochemical data were recorded and risk factors for cardiovascular disease were assessed. The data were analysed with chi square test, student t test and logistic regression (univariate and multivariate). Results. Seven hundred and ninety-eight subjects were included. The multivariate analyses demonstrated that, compared with controls, cases had an increased prevalence of metabolic risk factors for cardiovascular disease (odds ratio (OR) 2.8, 95% confidence interval (CI) 1.8-4.8, p = 0.001), including type 2 diabetes mellitus (OR 2.2, 95% CI 1.1-4.5, p = 0.018), high blood pressure (OR 5.1, 95% CI 2.6-10.1, p = 0.001), and high cholesterol levels (OR 2.7, 95% CI 1.3-5.5, p = 0.004). No differences were observed in the incidence of cardiovascular disease. Conclusion. Patients undergoing cholecystectomy had an increased prevalence of risk factors for cardiovascular disease, independent of age, sex, or body mass index.


REFERENCES

  1. Gonzalez-Perez A, Garcia Rodriguez LA. Gallbladder disease in the general population: association with cardiovascular morbidity and therapy. Pharmacoepidemiol Drug Saf 2007; 16: 524-31.

  2. Bortnichak EA, Freeman DH Jr., Ostfeld AM, et al. The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. Am J Epidemiol 1985; 121: 19-30.

  3. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 480-6.

  4. Kozak LJ, Hall MJ, Owings MF. National Hospital Discharge Survey: 2000 annual summary with detailed diagnosis and procedure data. Vital and health statistics. Series 13, Data from the National Health Survey 2002:1-194.

  5. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (second of two parts). New Engl J Med 1978; 299: 1221-7.

  6. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (first of two parts). New Engl J Med 1978; 299: 1161-7.

  7. Mendez-Sanchez N, Chavez-Tapia NC, Uribe M. The role of dietary fats in the pathogenesis of gallstones. Front Biosci 2003; 8: e420-e427.

  8. Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2011; 140: 508-16.

  9. Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia NC, et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol 2005; 100: 827-30.

  10. Mendez-Sanchez N, Zamora-Valdes D, Flores-Rangel JA, et al. Gallstones are associated with carotid atherosclerosis. Liv Int 2008; 28: 402-6.

  11. Wysowski DK, Goldberg EL, Comstock GW, et al. A study of a possible association between breast cancer and gallbladder disease. Am J Epidemiol 1986; 123: 532-43.

  12. Cho JY, Han HS, Yoon YS, et al. Risk factors for acute cholecystitis and a complicated clinical course in patients with symptomatic cholelithiasis. Arch Surg 2010; 145: 329-33; discussion 333.

  13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.

  14. Khan HN, Harrison M, Bassett EE, et al. A 10-year follow-up of a longitudinal study of gallstone prevalence at necropsy in South East England. Dig Dis Sci 2009; 54: 2736-41.

  15. Nilsson E, Fored CM, Granath F, et al. Cholecystectomy in Sweden 1987-99: a nationwide study of mortality and preoperative admissions. Scand J Gastroenterol 2005; 40: 1478-85.




2020     |     www.medigraphic.com